MYDAYIS
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
54092-477 -
Package NDC
54092-477-01 -
Application number
NDA022063 -
SPL ID
13a2ab7d-af84-4e46-a58f-9e9c17b5c0e5 -
SPL set ID
141a7970-3f06-44ea-9ab7-aeece2c085fc -
UNII
O1ZPV620O4 -
UNII
G83415V073 -
UNII
JJ768O327N -
UNII
6DPV8NK46S -
RxCUI
1927610 -
RxCUI
1927616 -
RxCUI
1927617 -
RxCUI
1927619 -
RxCUI
1927630 -
RxCUI
1927632 -
RxCUI
1927637 -
RxCUI
1927639
What the source publishes
- Labeler
- Takeda Pharmaceuticals America, Inc.
- Active ingredients
- DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, and AMPHETAMINE SULFATE
- Form
- CAPSULE, EXTENDED RELEASE
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- NDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
- MYDAYIS
- DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, and AMPHETAMINE SULFATE
- DEXTROAMPHETAMINE SULFATE
- DEXTROAMPHETAMINE SACCHARATE
- AMPHETAMINE ASPARTATE MONOHYDRATE
- AMPHETAMINE SULFATE
Complete source data
{
"name": "MYDAYIS",
"splId": "13a2ab7d-af84-4e46-a58f-9e9c17b5c0e5",
"labels": [
{
"setId": "141a7970-3f06-44ea-9ab7-aeece2c085fc",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=141a7970-3f06-44ea-9ab7-aeece2c085fc",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=141a7970-3f06-44ea-9ab7-aeece2c085fc"
}
],
"routes": [
"ORAL"
],
"labeler": "Takeda Pharmaceuticals America, Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (54092-477-01)",
"package_ndc": "54092-477-01",
"identifierStatus": "well-formed",
"marketing_start_date": "20170620"
}
],
"productId": "54092-477_13a2ab7d-af84-4e46-a58f-9e9c17b5c0e5",
"useDomain": "unknown",
"dosageForm": "CAPSULE, EXTENDED RELEASE",
"productNdc": "54092-477",
"deaSchedule": "CII",
"genericName": "DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, and AMPHETAMINE SULFATE",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "DEXTROAMPHETAMINE SULFATE",
"strength": "12.5 mg/1"
},
{
"name": "DEXTROAMPHETAMINE SACCHARATE",
"strength": "12.5 mg/1"
},
{
"name": "AMPHETAMINE ASPARTATE MONOHYDRATE",
"strength": "12.5 mg/1"
},
{
"name": "AMPHETAMINE SULFATE",
"strength": "12.5 mg/1"
}
],
"applicationNumber": "NDA022063",
"marketingCategory": "NDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20170620",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"unii": [
"O1ZPV620O4",
"G83415V073",
"JJ768O327N",
"6DPV8NK46S"
],
"rxcui": [
"1927610",
"1927616",
"1927617",
"1927619",
"1927630",
"1927632",
"1927637",
"1927639"
],
"spl_set_id": [
"141a7970-3f06-44ea-9ab7-aeece2c085fc"
],
"manufacturer_name": [
"Takeda Pharmaceuticals America, Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:54092-477_13a2ab7d-af84-4e46-a58f-9e9c17b5c0e5"